Not all stem cells are created equal part 4

Stem cell 1

 

To develop criteria that identify patients likely to benefit from regenerative therapies, it is important to identify functional indices associated with improved outcomes. Analysis from some trials support the importances of cell and patient characteristics in predicting clinical outcomes. In FOCUS-HF (First Bone Marrow Mononuclear Cell United States Study in Heart Failure) assessing effects of intramyocardial autologous bone marrow mononuclear cells in patients with no option chronic heart failure, younger patients (≤60 years)  had significantly higher numbers of mesenchimal progenitor cells  versus those >60 years. Younger patients also had significant improvement in maximal oxygen consumption (VO2 max) versus age-matched reference subjects while older patients did not, identifying age as an important modifier of therapeutic effect.

About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s